Davis Polk is advising Xponential Fitness on the offering, and Latham & Watkins is advising the underwriters involved. Xponential Fitness, Inc. has announced the pricing of...
Xponential Fitness’ $122.5 Million Secondary Offering of Class A Common Stock
Expro’s $151.8 Million Secondary Offering
Davis Polk advised the joint book-running managers involved in the offering, while Gibson Dunn and Van Campen Liem advised Expro. The selling shareholders were assisted by...
Cactus’ $172.5 Million Offering of Common Stock
Davis Polk advised Cactus Inc. on the stock offering and Simpson Thacher advised the underwriters involved. Cactus Inc. announced its $172.5 million follow-on offering of 3,224,300 shares of...
Skyward Specialty’s $134 Million Upsized Initial Public Offering
DLA Piper advised Skyward Specialty, while Latham & Watkins LLP represented the underwriters in the offering. Skyward Specialty Insurance Group, Inc., a specialty insurance company, delivering...
Acrivon Therapeutics’ $99.4 Million Initial Public Offering
Goodwin Procter advised the underwriters on the deal. Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines...
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Nuvalent’s $264.5 Million Equity Offering
Simpson Thacher represented the underwriters in the offering. Nuvalent, Inc. (“Nuvalent”) executed its registered follow-on offering of 7,895,522 shares of Class A common stock. The offering...
Immunic’s $60 Million Private Placement Equity Financing
Covington represented the placement agents on the deal. Immunic, Inc. (Nasdaq: IMUX) (“Immunic” or the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of selective oral...
VectivBio’s $125 Million Shares Offering
Latham & Watkins represented the underwriters in the offering. Homburger advised VectivBio. VectivBio Holding AG (Nasdaq: VECT) has announced the pricing of an underwritten offering of 16,700,000...
Gamida Cell’s $20 Million Shares Offering
Davis Polk advised the representative of the underwriters in the offering. Gamida Cell Ltd. announced the $20 million SEC-registered follow-on offering of 12,905,000 ordinary shares. The ordinary shares...
First Watch Restaurant’s Secondary Public Offering
Latham & Watkins represented the underwriters in the offering. First Watch Restaurant Group, Inc. (NASDAQ: FWRG), the Daytime Dining concept serving breakfast, brunch and lunch, has...
POINT Biopharma’s $125 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development and global access to life-changing...